Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03168659 · ClinicalTrials.gov registry record · NA
CardioFocus HeartLight Post-Approval Study
A NA study of Atrial Fibrillation, sponsored by CardioFocus.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 4
- Study locations
NCT03168659: Recruiting NA study of Atrial Fibrillation, sponsored by CardioFocus.
NCT03168659 is a NA study of Atrial Fibrillation that is actively recruiting participants, run by CardioFocus. The registered enrollment target is 250 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03168659, a NA study of Atrial Fibrillation, is actively recruiting participants, sponsored by CardioFocus.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.
Primary Outcome
The outcome will be assessed from 91 days post procedure through 12 months
Conditions Studied
Interventions
- PROCEDURE Ablation
- DEVICE HeartLight
Study Locations (4)
Arizona
- University of Arizona Sarver HeartCenter - Tucson
Illinois
- University of Illinois - Chicago
New York
- Mount Sinai Hospital - New York
Virginia
- University Of Virginia Health System - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2017-06-16 |
| Est. Completion | 2028-10 |
| Phase | NA |
What NCT03168659 shows while recruiting
NCT03168659 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Ablation is the first listed.
NCT03168659 reports a single indexed study location in Arizona, Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT03168659 about?
NCT03168659 is a clinical study titled "CardioFocus HeartLight Post-Approval Study". This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.
What is the current status of trial NCT03168659?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2017-06-16. Estimated completion is 2028-10.
What conditions does trial NCT03168659 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT03168659?
The interventions under investigation include: Ablation (PROCEDURE), HeartLight (DEVICE).
Who is sponsoring clinical trial NCT03168659?
This trial is sponsored by CardioFocus, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03168659 being conducted?
This trial has 4 study locations across Arizona, Illinois, New York, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03168659's enrollment target sits among peer trials
250 92nd of 202 higher than 111 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI